SCHEMBL19081962

SCHEMBL19081962

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5cc7c(cc56)oc5ccc6ccccc6c57)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.34
CYP1B1 Q16678 1/20 0.34
ABCG2 Q9UNQ0 7/20 0.34
TDP1 Q9NUW8 3/20 0.33
PAX8 Q06710 2/20 0.33
NPC1 O15118 2/20 0.33
AHR P35869 2/20 0.33
CYP1A2 P05177 2/20 0.33
RAB9A P51151 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
PGR P06401 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081877 0.96 ABCG2 (0.38) CYP1A1CYP1B1ABCG2TDP1PAX8
SCHEMBL19081822 0.93 ABCG2 (0.40) CYP1A1CYP1B1ABCG2TDP1PAX8
SCHEMBL19081878 0.91 ABCG2 (0.38) CYP1A1CYP1B1ABCG2TDP1PAX8
SCHEMBL19081930 0.89 PSD (0.33) CYP1A1ABCG2TDP1PAX8NPC1
SCHEMBL19082012 0.89 ABCG2 (0.38) CYP1A1ABCG2TDP1PAX8NPC1
SCHEMBL19081978 0.88 ABCG2 (0.35) CYP1A1CYP1B1ABCG2TDP1PAX8
SCHEMBL22680423 0.87 ABCG2 (0.40) CYP1A1CYP1B1ABCG2TDP1PAX8
SCHEMBL19081793 0.87 PSD (0.34) CYP1A1ABCG2TDP1PAX8NPC1
SCHEMBL17944803 0.86 SMN1; SMN2 (0.35) CYP1A1CYP1B1CYP1A2RAB9AESR1
SCHEMBL17944376 0.86 CASP3 (0.33) CYP1A1CYP1B1TDP1NPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.